Advertisement
News
Subscribe to MDT Magazine News

Perrigo Company to Present at the 29th Annual J.P. Morgan Healthcare Conference

January 7, 2011 7:32 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., Jan. 7, 2011 /- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, at 11:00 AM (PST) at the Westin St. Francis Hotel in San Francisco,...

TOPICS:

Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices Offers Sessions on Orthopedic and Cardio Applications

January 7, 2011 7:32 am | by Bio-Medicine.Org | Comments

LOS ANGELES, Jan. 7, 2011 /- MD+DI ( Medical Device & Diagnostic Industry ), MPMN ( Medical Product Manufacturing News ), and OrthoTec, UBM Canon's Medical Device Media Group leading brands, today announced session topics for the upcoming virtual event, Design Trends: Technological...

TOPICS:

Med device maker Doctors Research lands $7.7M

January 7, 2011 6:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Doctors Research Group Inc. of Southbury, Conn., a maker of a bone cement for repairing cranial defects, has raised $7.7 million of a planned $15 million financing round, according to a regulatory filing.

Advertisement

Hologic pays $125M to acquire Interlace Medical

January 7, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Hologic Inc., a Bedford developer of diagnostics tools for women's health, has acquired Interlace Medical Inc., a Framingham medical device maker, for $125 million.

Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections

January 7, 2011 5:37 am | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Jan. 7, 2011 /- Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of...

TOPICS:

WaferGen to Present at OneMedForum San Francisco 2011

January 7, 2011 5:37 am | by Bio-Medicine.Org | Comments

FREMONT, Calif., Jan. 7, 2011 /- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a leading developer of state-of-the-art genomic analysis systems, today announced that it will present an overview of the company at the 4th Annual OneMedForum Business Development and Investment...

TOPICS:

ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics

January 7, 2011 5:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced that it has signed a term sheet to acquire a private company that holds certain rights and know-how to poloxamer-based therapeutics. The term sheet is non-binding on both ADVENTRX and the target...

TOPICS:

ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million

January 7, 2011 5:36 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Jan. 7, 2011 /- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX ) announced today that it has entered into definitive agreements to sell 8,184,556 units in a registered direct offering to RA Capital Management, certain healthcare-focused investors, and other institutional...

TOPICS:
Advertisement

Amarin Announces Underwriters' Exercise of Over-Allotment Option

January 7, 2011 5:35 am | by Bio-Medicine.Org | Comments

MYSTIC, Conn. and DUBLIN, Jan. 7, 2011 /- Amarin Corporation plc (Nasdaq: AMRN ) (the "Company"), a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today announced that, in connection with its previously announced underwritten public offering of American...

TOPICS:

Federal Register: Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical Devices: Recommended Glossary and Educational Outreach To Suppo...

January 7, 2011 4:31 am | by U.S. Food & Drug Administration | Comments

The guidance document provides guidance for the voluntary use of selected symbols in place of text in labeling. It provides the labeling guidance required for: (1) In vitro diagnostic devices (IVDs), intended for professional use under 21 CFR 809.10...

TOPICS:

Hologic buys Interlace for $125 million

January 7, 2011 3:45 am | by The Associated Press | Comments

Hologic Inc., which makes mammogram systems and other women's health diagnostic tools, said Friday it bought Interlace Medical Inc. for $125 million in cash, in a move to boost its position in the women's health care market.Interlace, based in Framingham, Mass., makes the MyoSure hysteroscopic...

Chiasma kicks up summer debt round to $5M

January 7, 2011 3:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Chiasma Inc., a Newton Center-based biotech, has added to its debt financing round announced last summer, bumping it up from $2 million to $5 million of a planned $6 million, according to federal documents.

Hologic Acquires Interlace Medical

January 7, 2011 2:33 am | by Bio-Medicine.Org | Comments

BEDFORD, Mass., Jan. 7, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today it has acquired...

TOPICS:

LumaSense expands with infrared acquisition

January 7, 2011 1:37 am | by I-Micronews | Comments

Camera and sensor company buys L-3 Communications subsidiary InfraredVision Technology Corp.

Carbon nanotubes as optical antennae

January 7, 2011 1:37 am | by I-Micronews | Comments

Just as walkie-talkies transmit and receive radio waves, carbon nanotubes can transmit and receive light at the nanoscale, Cornell University researchers have discovered.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading